SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dooley, M. J.
Right arrow Articles by Vernon, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dooley, M. J.
Right arrow Articles by Vernon, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reproducibility of treatment methodologies detailed in contemporary clinical trial reports

Michael Joseph Dooley, B Pharm, Grad Dip Hosp Pharm

Pharmacy Department, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia, Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Parkville, Victoria, Australia

Joanne Vernon, B Pharm, B Pharm Sc (Hons)

Pharmacy Department, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia

Objective. To assess the reproducibility of treatment methodology detailed in contemporary published clinical trial reports.

Design. Published articles focusing on clinical trials involving the administration of chemotherapy for the treatment of cancer were selected. The data required for the administration of chemotherapy was determined by an experienced oncology pharmacist.

Outcome measures. The degree of potential impact of the omission of relevant detail was assessed. The overall reproducibility of the methodology was then classified as reproducible, reproducible with further literature evaluation, or not reproducible without communication with the authors.

Results. Ninety-two articles were reviewed. Ninety percent of articles omitted data required to enable reproduction of the methodology. Of these, 5.4% omitted essential data which could only be obtained by communication with the authors. Over 57% of articles required further detailed literature evaluation before the methodology could be reproduced. A number of articles contained errors or ambiguity.

Discussion. The focus of the article and journal contributed to the completeness of the methodology. Guidelines for the preparation of manuscripts for publication in biomedical journals need to be reviewed. Practitioners and editors must be cognizant of the limitations of published methodologies.

Conclusion. A significant number of articles contained omissions, ambiguity and even errors, which would prevent the methodology being reproduced. The majority of methodologies could be reproduced with the interpretation of an experienced oncology pharmacist, or by utilising resources for detailed literature evaluation.

Key Words: Oncology • literature • published • chemotherapy • protocols • reproducibility

Journal of Oncology Pharmacy Practice, Vol. 6, No. 2, 50-54 (2000)
DOI: 10.1177/107815520000600203


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement